Hofseth BioCare ASA (Hofseth BioCare ASA) ROCE % : -52.76% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Hofseth BioCare ASA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hofseth BioCare ASA's annualized ROCE % for the quarter that ended in Mar. 2024 was -52.76%.

Hofseth BioCare ASA ROCE % Historical Data

The historical data trend for Hofseth BioCare ASA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA ROCE % Chart

Hofseth BioCare ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-47.02

-32.79

-37.22

-48.06

-50.43

Hofseth BioCare ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-62.33	16.16	-42.32	-129.81	-52.76

Hofseth BioCare ASA ROCE % Calculation

Hofseth BioCare ASA's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-9.398	/	( ( (41.602 - 17.432)	+	(36.98 - 23.876) )	/ 2 )
	=	-9.398	/	( (24.17	+	13.104)	/ 2 )
	=	-9.398	/	18.637
	=	-50.43 %

Hofseth BioCare ASA's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-9.696	/	( ( (36.98 - 23.876)	+	(36.818 - 13.166) )	/ 2 )
	=	-9.696	/	( ( 13.104	+	23.652 )	/ 2 )
	=	-9.696	/	18.378
	=	-52.76 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Hofseth BioCare ASA (OTCPK:HOFBF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hofseth BioCare ASA ROCE % Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hofseth BioCare ASA (Hofseth BioCare ASA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hofseth BioCare ASA (OTCPK:HOFBF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

HBCO:Sweden HBC:Norway HBQ:Germany

Address

Kipervikgata 13, Aalesund, NOR, 6003

Website

https://www.hofsethbiocare.com

Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.